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CRISPR/Cas9-mediated editing 
of Δ5 and Δ6 desaturases 
impairs Δ8-desaturation and 
docosahexaenoic acid synthesis in 
Atlantic salmon (Salmo salar L.)
Alex K. Datsomor1, Rolf E. olsen1,2, Nikola Zic1, Angelico Madaro  2, Atle M. Bones1, 
Rolf B. edvardsen2, Anna Wargelius2 & Per Winge1*
The in vivo functions of Atlantic salmon fatty acyl desaturases (fads2), Δ6fads2-a, Δ6fads2-b, 
Δ6fads2-c and Δ5fads2 in long chain polyunsaturated fatty acid (LC-PUFA) synthesis in salmon and 
fish in general remains to be elucidated. Here, we investigate in vivo functions and in vivo functional 
redundancy of salmon fads2 using two CRISPR-mediated partial knockout salmon, Δ6abc/5Mt 
with mutations in Δ6fads2-a, Δ6fads2-b, Δ6fads2-c and Δ5fads2, and Δ6bcMt with mutations in 
Δ6fads2-b and Δ6fads2-c. F0 fish displaying high degree of gene editing (50–100%) were fed low LC-
PUFA and high LC-PUFA diets, the former containing reduced levels of eicosapentaenoic (20:5n-3) and 
docosahexaenoic (22:6n-3) acids but higher content of linoleic (18:2n-6) and alpha-linolenic (18:3n-
3) acids, and the latter containing high levels of 20:5n-3 and 22:6n-3 but reduced compositions of 
18:2n-6 and 18:3n-3. The Δ6abc/5Mt showed reduced 22:6n-3 levels and accumulated Δ6-desaturation 
substrates (18:2n-6, 18:3n-3) and Δ5-desaturation substrate (20:4n-3), demonstrating impaired 
22:6n-3 synthesis compared to wildtypes (WT). Δ6bcMt showed no effect on Δ6-desaturation compared 
to WT, suggesting Δ6 Fads2-a as having the predominant Δ6-desaturation activity in salmon, at 
least in the tissues analyzed. Both Δ6abc/5Mt and Δ6bcMt demonstrated significant accumulation of 
Δ8-desaturation substrates (20:2n-6, 20:3n-3) when fed low LC-PUFA diet. Additionally, Δ6abc/5Mt 
demonstrated significant upregulation of the lipogenic transcription regulator, sterol regulatory 
element binding protein-1 (srebp-1) in liver and pyloric caeca under reduced dietary LC-PUFA. Our 
data suggest a combined effect of endogenous LC-PUFA synthesis and dietary LC-PUFA levels on 
srebp-1 expression which ultimately affects LC-PUFA synthesis in salmon. Our data also suggest Δ8-
desaturation activities for salmon Δ6 Fads2 enzymes.
The health benefits of fish oil particularly eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3) 
have been demonstrated by many studies. These omega-3 long chain (≥C20) polyunsaturated fatty acids (n-3 
LC-PUFAs) are known to reduce incidences of cardiovascular diseases, inflammatory disorders and neurolog-
ical pathologies in humans1–6. Farmed fish, including Atlantic salmon (Salmo salar L.) currently provides an 
increasing proportion of n-3 LC-PUFAs in human diet7–9. Consequently, there has been interest in understand-
ing endogenous synthesis and regulation of LC-PUFAs in Atlantic salmon, which is the most farmed species 
of salmonids9,10. The LC-PUFA biosynthetic pathway in Atlantic salmon is similar to that of majority of other 
vertebrates7,9,11 (Fig. 1). Biosynthesis of LC-PUFAs in vertebrates requires sequential desaturation and elongation 
of the C18 PUFAs, α-linolenic acid (18:3n-3) and linoleic acid (18:2n-6). Synthesis of 20:5n-3 is achieved via 
Δ6-desaturation of 18:3n-3 to 18:4n-3, which is elongated to 20:4n-3 followed by Δ5-desaturation. Synthesis 
of arachidonic acid (20:4n-6) requires the same enzymes and involves Δ6-desaturation of 18:2n-6 to 18:3n-6 
that is elongated to 20:3n-6 followed by Δ5-desaturation12. Alternatively, 18:3n-3 and 18:2n-6 may be elongated 
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to eicosatrienoic acid (20:3n-3) and eicosadienoic acid (20:2n-6) respectively, followed by Δ8-desaturation to 
20:4n-3 and 20:3n-613, which are respectively converted to 20:5n-3 and 20:4n-6 via Δ5-desaturation. Biosynthesis 
of 22:6n-3 requires two elongation steps from 20:5n-3, a second Δ6-desaturation and a chain-shortening step 
by peroxisomal β-oxidation in the so called “Sprecher pathway”14. 22:6n-3 may be directly synthesized through 
Δ4-desaturation of docosapentaenoic acid (22:5n-3)15. However, the latter pathway may not exist in Atlantic 
salmon.
The capacity for LC-PUFA synthesis in any species depends on complementary activities of fatty acyl desatu-
rases (Fads2) and elongases of very long chain fatty acid (Elovls). Multiple Atlantic salmon Δ6 fads2 (Δ6fads2-a, 
Δ6fads2-b and Δ6fads2-c) and Δ5fads2 genes have been cloned and functionally characterized through het-
erologous expression in the yeast Saccharomyces cerevisiae16–18. The salmon Δ6 fads2 genes encode proteins 
that predominantly possess Δ6-desaturation activity towards 18:3n-3,18:2n-6, 24:4n-6 and 24:5n-317–19, while 
Δ5fads2 gene encodes an enzyme with predominant Δ5-desaturation activity towards 20:4n-3 and 20:3n-6 
with some Δ6-desaturation of 18:3n-3,18:2n-6, 24:4n-6 and 24:5n-316,19. Additionally, the salmon elovl genes, 
elovl2, elovl4, elovl5a and elovl5b have been cloned and functionally characterized through in vitro studies in S. 
cerevisiae16,20,21. Salmon elovl2 and elovl4 encode proteins that efficiently elongate C20 and C22 LC-PUFAs20,21, 
whereas elovl5a and elovl5b encode enzymes that elongate C18 and C20 PUFAs with marginal activities towards 
C22 LC-PUFAs16,21. The Atlantic salmon LC-PUFA pathway responds to dietary PUFA compositions. Significant 
upregulation of Δ6fads2-a and Δ6fads2-b17 as well as elovl5b and elovl221 genes was observed in salmon fed 
diets rich in 18:3n-3 and 18:2n-6 but devoid of 20:5n-3 and 22:6n-3. Similarly, a diet high in 18:3n-3 and 18:2n-6 
increases enzymatic activity of fatty acyl desaturases and elongases for elongation of very long chain fatty acid 
in Atlantic salmon, compared to a diet high in 20:5n-3 and 22:6n-322. Dietary fatty acids control lipogenic gene 














































Figure 1. The long chain polyunsaturated fatty acid biosynthetic pathway from α-linolenic (18:3n-3) and 
linoleic (18:2n-6) acids. Enzymes that are mutated by CRISPR/Cas9 in the current study are in bold. The 
activities of the LC-PUFA synthetic enzymes in the pathway have previously been deduced in vitro through 
heterologous expression in S. cerevisiae of Atlantic salmon Δ6fads2-a18, Δ6fads2-b and Δ6fads2-c17, and of 
elovl2 and elovl5 (elovl5a and elovl5b)16,21. Additionally, salmon Δ6fads2-b and Δ6fads2-c have been shown to 
encode proteins that possess Δ8-desaturation activity in vitro, converting 20:3n-3 and 20:2n-6 to 20:4n-3 and 
20:3n-6 respectively13. Elovl5 is believed to convert 18:3n-3 and 18:2n-6 to 20:3n-3 and 20:2n-6 respectively38. 
PUFAs that are affected by the CRISPR/Cas9 mutations in our study are marked with arrows. Fatty acids that 
have accumulated in both of our mutants, Δ6abc/5Mt and Δ6bcMt are marked with bold green arrows and those 
that accumulated mostly in only Δ6abc/5Mt are marked with narrow green arrows. LC-PUFA that has shown 
reduced percentage composition in Δ6abc/5Mt is marked with a red arrow.
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(Lxr-α) and sterol regulatory element binding protein-1 (Srebp-1)23,24. An Lxr-α-response element has been iden-
tified within the promoter of Srebp-1c and was shown to be the primary site mediating LC-PUFA-dependent 
regulation of Srebp-1c in rat23. In this study, 22:6n-3-mediated repression of Srebp-1c expression was found to 
be Lxr-α-dependent in rat hepatocyte assays23. Indeed, in assessing LC-PUFA biosynthetic capacity of Atlantic 
salmon and other salmonids, such as rainbow trout, Artic charr and brown trout, numerous in vitro studies 
involving heterologous expression13,16,17,20,21 and fatty acid desaturation/elongation assays in both hepatocytes 
and enterocytes22,25,26 have been performed. To broaden and provide detailed insight into the in vivo functions 
of genes encoding salmon LC-PUFA biosynthetic enzymes, as well as understand nutritional and transcriptional 
regulation of LC-PUFA biosynthesis, in vivo functional studies are required.
Programmable DNA endonucleases have been used for in vivo functional studies in many animal models 
over the past years. Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) 
system27–29 has been proven to be an efficient and cost-effective genome editing tool30. CRISPR-induced frame 
shift insertions and deletions (indels) create loss-of-gene function by altering protein-coding region or by pre-
mature termination codons (PTCs) that produce truncated proteins as well as signal the nonsense-mediated 
mRNA decay (NMD) pathway that recognizes and degrade aberrant mRNAs31. CRISPR/Cas9 has been success-
fully used to induce biallelic mutations in the F0 of zebrafish32 and Atlantic salmon33,34 allowing for phenotypic 
analysis directly in the F0 animals. Taking advantage of previous heterologous studies in S. cerevisiae reporting 
Δ8-desaturation activities for salmon Δ6 Fads2-b and Δ6 Fads2-c13, together with data from initial in vitro stud-
ies ranking Δ6-desaturation activities of the salmon Δ6 desaturases as Δ6 Fads2-a > Δ6 Fads2-b > Δ6 Fads2-c, 
we generated partial salmon knockouts in two different combinations (Δ6abc/5Mt and Δ6bcMt) using established 
CRISPR/Cas9 protocols for Atlantic salmon33,34. Δ6bcMt provided insights into in vivo Δ6-desaturation capacity 
as well as in vivo Δ8-desturation activities of the salmon Δ6 Fads2-b and Δ6 Fads2-c. Comparison between 
Δ6abc/5Mt and Δ6bcMt provided some understanding of the predominant Δ6-desaturation roles of Δ6 Fads2-a 
in vivo compared to Δ6 Fads2-b and Δ6 Fads2-c. Due to the long generation time of salmon, F0 fish with high 
percentage of targeted mutations in genes of interest were used in the functional analysis. We could thereby 
demonstrate that 20:4n-3 and 18:3n-3/18:2n-6 is the main in vivo substrate of salmon Δ5 Fads2 and Δ6 Fads2, 
respectively. Additionally, we show that the salmon Δ6 Fads2 possess Δ8-desaturation activities towards 20:3n-3 
and 20:2n-6 in vivo. We also observed that Δ6fads2-a has a more dominant role compared to its paralogous genes 
Δ6fads2-b and Δ6fads2-c in 18:3n-3 and 18:2n-6 desaturation under the given conditions and in tissue types 
analyzed. Our data further suggest Srebp-1 as a major transcription regulator of salmon LC-PUFA biosynthesis 
and show that the status of endogenous LC-PUFA synthesis as well as dietary LC-PUFA composition control 
expression of srebp-1.
Results
Generation of Δ6abc/5Mt and Δ6bcMt, confirmation of CRISPR/Cas9-induced mutations and 
Growth performance. Two groups of CRISPR/Cas9-mutated salmon, Δ6abc/5Mt and Δ6bcMt were gener-
ated as previously described in Atlantic salmon33. To provide a suitable visual screening of the knockouts from 
WT, the slc45a2 gene involved in melanin synthesis was simultaneously mutated with the fads2 genes. CRISPR/
Cas9-induced indels in the fads2 genes were highly correlated with the albino phenotype (Supplemental Table 1) 
in line with previously reported results34,35. Mutations were confirmed through direct sequencing of PCR frag-
ments isolated from gels and sub-cloned PCR products flanking regions around each target site. CRISPR/Cas9-
induced mutations were detected as scrambled peaks from target sites in DNA sequencing chromatograms 
(Supplemental Fig. 1A–E). Mutations were observed in all targeted fads2 genes, Δ6fads2-a, Δ6fads2-b, Δ6fads2-c 
and Δ5fads2 in individuals of Δ6abc/5Mt group (Supplemental Fig. 1A–D) and in PCR products obtained from 
co-amplification of Δ6fads2-b and Δ6fads2-c in Δ6bcMt individuals (Supplemental Fig. 1E). The results were 
validated by sequencing of sub-cloned PCR-products. The Δ6abc/5Mt group has predominantly 5 bp deletions at 
CRISPR-target sites regardless of the gene targeted. Other different types of indels including deletions and inser-
tions were observed. The predominant indel in Δ6bcMt group is a 4 bp deletion in addition to other different types 
of insertions and deletions. To study the impact of fads2 gene knockout and dietary LC-PUFA levels on endoge-
nous LC-PUFA biosynthesis, fish were fed low LC-PUFA and high LC-PUFA diets (Supplemental Table 2). Prior 
to the feeding trial, fish were fed a standard commercial diet (Supplemental Table 2) shortly after hatching, where 
Δ6bcMt and Δ6abc/5Mt were notably similar in size with estimated average weight of 49 g but smaller than WT 
with approximate weight of 85 g (Table 1). Consequently, fish were fed 22:6n-3 (DHA)-rich diets (Supplemental 
Table 2) to enhance growth. Of all three groups of experimental fish, Δ6abc/5Mt displayed reduced average weight 
regardless of dietary treatment with DHA-rich, low LC-PUFA or high LC-PUFA diet compared to Δ6bcMt and 
WT (Table 1). Surprisingly, average weights of all experimental groups seem to be higher when fed low LC-PUFA 
diet compared to fish fed high dietary LC-PUFA, with Δ6bcMt showing the highest average weight (Table 1).
Δ6abc/5Mt shows impaired synthesis of 22:6n-3. To understand in vivo functions and evaluate pos-
sible in vivo functional redundancy of the desaturases, CRISPR-mutated salmon from groups, Δ6abc/5Mt and 
Δ6bcMt were fed low and high LC-PUFA diets for 54 days. Liver phospholipid PUFA composition in all three fish 
groups, especially of 18:2n-6 and 18:3n-3 showed a positive correlation with the dietary contents after the 54 days 
of feeding (Fig. 2A,B). Additionally, we observed an accumulation of liver phospholipid 18:3n-3, 18:2n-6, 20:4n-3 
and 22:5n-3 in Δ6abc/5Mt compared with WTs (Fig. 2A). This was accompanied by a reduction in the levels of 
liver phospholipid 22:6n-3. Similar observation was made from white muscle phospholipids of Δ6abc/5Mt group 
fed low LC-PUFA diet even though changes were subtle especially when fed a high LC-PUFA diet (Supplemental 
Fig. 2). In general, there were no significant changes in the levels of liver phospholipid 18:3n-3 and 18:2n-6 in the 
Δ6bcMt group compared to WT (Fig. 2B). However, a significant but unexpected accumulation of 20:4n-3 was 
observed in the liver of Δ6bcMt group fed a low LC-PUFA diet (Fig. 2B).
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Δ6abc/5Mt and Δ6bcMt demonstrate accumulation of Δ8-desaturation substrates. Analysis 
of PUFA composition in liver phospholipids revealed a clear accumulation of precursors for Δ8-desaturation 
(20:3n-3 and 20:2n-6) in Δ6abc/5Mt and Δ6bcMt compared with the WTs (Fig. 3). This was only obvious in fish 
that were fed low LC-PUFA diet containing high levels of 18:3n-3 and 18:2n-6 compared to the high LC-PUFA 
diet (Fig. 3). Furthermore, the levels of liver phospholipid 20:3n-3 and 20:2n-6 correlate well with dietary levels of 
the C18 precursors (Fig. 3 and Supplemental Table 2), with fish fed low LC-PUFA diet generally having higher lev-
els of the C20 Δ8-desaturation substrates compared with fish fed high LC-PUFA diet. There was no change in liver 
phospholipid 20:3n-3 and 20:2n-6 in Δ6abc/5Mt and Δ6bcMt that were fed high LC-PUFA diet (Fig. 3). Similar 
observation was made from white muscle phospholipid of Δ6abc/5Mt and Δ6bcMt fish compared with the WTs 
(Supplemental Fig. 3A). Additionally, accumulation of the C20 Δ8-desaturation substrates was observed in white 
muscle triacylglycerol (TAG) of Δ6abc/5Mt and Δ6bcMt that were fed low LC-PUFA diet (Supplemental Fig. 3B).
Δ6abc/5Mt shows impaired liver Δ8-desaturation of 14C-20:3n-3 and n-3 PUFA synthesis from 
14C-18:3n-3. To validate our observations, hepatocytes from WTs and Δ6abc/5Mt salmon that were fed low 
LC-PUFA diet were analyzed for the ability to convert radiolabeled 18:3n-3 to n-3 PUFAs. Hepatocytes were incu-
bated with 14C-18:3n-3 and the percentages of radioactivity recovered from 18:4n-3, 20:4n-3, 20:5n-3 and 22:5n-3 
individually determined and pooled together. The percentage of 14C-20:3n-3, a substrate for Δ8-desaturation was 
also determined. Desaturation/elongation capacity of hepatocytes from Δ6bcMt could not be assayed as a result 
of reduced radioactivity signal strength from samples, most likely due to limiting starting materials. Hepatocytes 
from Δ6abc/5Mt salmon showed a clear accumulation of 14C-20:3n-3 and reduced percentage radioactivity recov-
ered as the PUFAs (18:4n-3, 20:4n-3, 20:5n-3 and 22:5n-3) compared to WTs (Fig. 4). However, these results were 
not statistically significant. Furthermore, it appears 22:6n-3 being relatively longer and with higher degree of 
unsaturation could not migrate from the origin and was not quantified with certainty, this was unexpected as the 
recommended experimental protocols were followed.
Δ6abc/5Mt demonstrates low dietary LC-PUFA-induced mRNA expression of srebp-1. The 
mRNA expression levels of the lipogenic transcription regulators; srebp-1 and srebp-2 in Δ6abc/5Mt and Δ6bcMt 
groups, were measured in liver and intestine (pyloric caeca) using RT-qPCR. We observed significant (p < 0.05) 
upregulation of srebp-1 in the liver and pyloric caeca of Δ6abc/5Mt salmon fed low LC-PUFA diet (Fig. 5A,B). 
Upregulation of srebp-1 was higher in the liver (≈2 folds) compared to pyloric caeca (≈1.5 folds). To validate 
the observed increased expression of srebp-1, we measured liver and intestinal (pyloric caeca) mRNA expres-
sion levels of fatty acid synthase-a (fas-a) and fas-b, which are key downstream target genes of Srebp-136. Liver 
fas-a and fas-b were upregulated in Δ6abc/5Mt fed a low LC-PUFA diet (Supplemental Fig. 4A,B), although not 
statistically significantly. The mRNA expression levels of intestinal fas-a and fas-b remain unchanged (data not 
shown). Additionally, no upregulation of srebp-1 was observed in Δ6abc/5Mt salmon fed a high LC-PUFA diet 
or in Δ6bcMt salmon fed either low or high LC-PUFA diet (Fig. 5A,B). Δ6abc/5Mt showed no significant change 
in the expression of srebp-2 (Fig. 5C,D). However, a significant reduction in the mRNA levels of srebp-2 was 
observed in the liver of Δ6bcMt when fed low LC-PUFA diet (Fig. 5C). The impact of the two dietary regimens 











WT** ≈85 — 72
Standard diet 227
Δ6abc/5Mt**/Δ6bcMt ≈49 — 72 each
Δ6abc/5Mt 85 ± 25a 19 ± 2a 36
DHA-rich diets 110Δ6bcMt 104 ± 25b 20 ± 2b 36
WT 176 ± 34c 24 ± 2c 36
Δ6abc/5Mt 203 ± 51ac 27 ± 2 6
Low LC-PUFA 
diet 54Δ6bc
Mt 281 ± 52b 30 ± 2 6
WT 250 ± 62ab 30 ± 5 6
Δ6abc/5Mt 171 ± 36c 26 ± 1 6
High LC-PUFA 
diet 54Δ6bc
Mt 191 ± 69ac 27 ± 3 6
WT 241 ± 47ab 29 ± 1 6
Table 1. Weights and lengths of experimental fish fed different dietary regimens. Shortly after hatching fish 
were fed a standard commercial diet followed by 22:6n-3 (DHA)-rich diets to enhance growth. Fish were 
subsequently fed two experimental diets, low LC-PUFA and high LC-PUFA diets. **Weights of WT and 
Δ6abc/5Mt were estimated, as experimental fish were weighed together in two groups or categories as Pit-
tagged (Δ6bcMt) or untagged (WT + Δ6abc/5Mt). At the time of switching from standard diet to 22:6n-3 
(DHA)-rich diets, we did not weigh Δ6abc/5Mt group separately but they were observed to have similar size 
as Δ6bcMt compared to WT. Weights and lengths of fish fed low and high LC-PUFA diets were analyzed by 
two-way ANOVA using dietary treatment and strain or genotype as experimental factors, followed by multiple 
comparisons of the means using Tukey HSD post-hoc test. Weights and lengths of fish fed DHA-rich diets 
were analyzed by one-way ANOVA using strain as experimental factor, followed by Tukey HSD post-hoc test. 
Different superscripts indicates statistical difference, p < 0.05.
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LC-PUFA diet relative to WTs fed high dietary LC-PUFA. The two diets had no significant effect on the expres-
sion of srebp-1 (Fig. 5E). However, a significant increase in the expression of srebp-2 was observed in the liver of 
WTs fed low LC-PUFA diet (Fig. 5F).
Δ6abc/5Mt and Δ6bcMt mutants show reduced expression of CRISPR/Cas9-targeted 
genes. RT-qPCR analysis of CRISPR-targeted genes showed reduced mRNA expression of Δ6fads2-a, 
Δ6fads2-b and Δ5fads2 in Δ6abc/5Mt, Δ6fads2-b and Δ6fads2-c in Δ6bcMt in both liver and pyloric caeca 
(Table 2). Unexpectedly, Δ5fads2 appears to be significantly downregulated in liver of Δ6bcMt. Expression of 































































































Figure 2. Δ6abc/5Mt shows impaired liver phospholipid 22:6n-3 synthesis, displayed as reduced phospholipid 
22:6n-3 levels and accumulation of 18:3n-3, 18:2n-6, 20:4n-3 and 22:5n-3 compared to WT (A). Δ6bcMt shows 
no significant effect on Δ6-desaturation substrates (18:3n-3 and 18:2n-6) and 22:6n-3 synthesis compared to 
WT, however, an unexpected accumulation of 20:4n-3 was observed when Δ6bcMt were fed low LC-PUFA diet 
(B). The wildtypes (WT), Δ6abc/5Mt and Δ6bcMt were fed low LC-PUFA and high LC-PUFA diets for 54 days. 
For easy comparison, the same WT data is presented both in A and B. Phospholipids were separated on high 
performance thin layer chromatography silica gel 60 plates. Fatty acid methyl esters (FAMEs) were prepared 
by acid-catalyzed transesterification and quantified by gas chromatography coupled with mass spectroscopy. 
Results are shown as mean ± standard deviation of liver samples from 3 fishes. Statistical differences between 
WT and CRISPR-mutated fish were determined using two-tailed t-test with unequal variance and are denoted 
as asterisks (*p ≤ 0.05 and **p < 0.01).
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Reduced mRNA expression of CRISPR-target genes appears to be relatively stronger in Δ6abc/5Mt fed on high 
LC-PUFA diet than on low LC-PUFA diet and appears to correlate well with mRNA expression of srebp-1. This 
observation was made both in the liver and pyloric caeca.
Discussion
The current study sought to understand in vivo functions of Atlantic salmon desaturases and to evaluate their 
levels of in vivo functional redundancy in LC-PUFA biosynthesis using two groups of CRISPR-mutated salmon, 
Δ6abc/5Mt with mutated Δ6fads2-a, Δ6fads2-b, Δ6fads2-c and Δ5fads2 genes and Δ6bcMt where only Δ6fads2-b 
and Δ6fads2-c were mutated. Additionally, nutritional and transcriptional regulation of Atlantic salmon 
LC-PUFA biosynthesis was investigated. Our data from Δ6abc/5Mt and Δ6bcMt salmon indicate that Δ6 Fads2-a 
is responsible for the largest proportion of Δ6-desaturation activity in liver, and that salmon Δ6 Fads2 have 
Δ8-desaturation activity towards 20:2n-6 and 20:3n-3 in vivo. Furthermore, we have shown that both the status 
of endogenous LC-PUFA synthesis and dietary LC-PUFA levels influence the expression of srebp-1, a major tran-
scription regulator that controls the expression of lipogenic enzymes involved in LC-PUFA synthesis37.
The Δ6abc/5Mt salmon demonstrated impaired synthesis of 22:6n-3, displayed as reduced levels of 22:6n-3 
and accumulation of Δ6-desaturation substrates (18:2n-6 and 18:3n-3) as well as 20:4n-3 which is a substrate 









WT WT Δ6abc/5 






























Δ6bcMt Δ6abc/5Mt Δ6bcMt Mt
Figure 3. Δ6abc/5Mt and Δ6bcMt accumulate 20:2n-6 and 20:3n-3 phospholipids in the liver when fed low LC-
PUFA diet rich in 18:2n-6 and 18:3n-3. The wildtypes (WT), Δ6abc/5Mt and Δ6bcMt were fed low LC-PUFA and 
high LC-PUFA diets for 54 days. Phospholipids were separated on high performance thin layer chromatography 
silica gel 60 plates. Fatty acid methyl esters (FAMEs) were prepared by acid-catalyzed transesterification and 
quantified by gas chromatography coupled with mass spectroscopy. Results for tissue fatty acid composition 
are shown as mean ± standard deviation of liver samples from 3 fishes. Statistical differences between WT 
and CRISPR-mutated fish were determined using two-tailed t-test with unequal variance and are denoted as 

































Figure 4. The degree of 14C-18:3n-3 desaturation in hepatocytes shown as percentage of radioactivity recovered 
in 20:3n-3, a substrate for Δ8-desaturation, and the overall impact of CRISPR-induced mutations in Δ6abc/5Mt 
on n-3 PUFA synthesis shown as percentage radioactivity recovered in n-3 PUFAs** (18:4n-3, 20:4n-3, 20:5n-3 
and 22:5n-3) determined individually but pooled together. Approximately 90% of radioactivity was recovered 
from 14C-18:3n-3 in all samples. Data represent mean ± standard deviation of 3 and 2 samples from WT and the 
Δ6abc/5Mt respectively.
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Figure 5. Δ6abc/5Mt showed low dietary LC-PUFA-induced expression of sterol regulatory element binding 
protein-1 (srebp-1) in the liver (A) and pyloric caeca (B). The Δ6abc/5Mt showed no significant effect on the 
expression of srebp-2 (C and D), however, mRNA expression of srebp-2 was downregulated in the liver of 
Δ6bcMt when fed low LC-PUFA diet (C).The mRNA expression of srebp-1 and srebp-2 in CRISPR-mutated fish 
was determined relative to wildtypes (WT), with WT set to 1. The impact of the two diets on the expression 
of srebp-1 and srebp-2 was determined by measuring mRNA expression in WT fed low LC-PUFA diet relative 
to WT fed high dietary LC-PUFA, with WT fed high LC-PUFA diet set to 1. Differences in dietary LC-PUFA 
showed no significant effect on mRNA expression of srebp-1 (E). However, WT fed low LC-PUFA diet showed 
upregulated mRNA expression of srebp-2 in the liver (F). WT, Δ6abc/5Mt and Δ6bcMt were fed low LC-PUFA 
and high LC-PUFA diets for 54 days. All qPCR data were analyzed using qBase+ 51 which determined statistical 
differences between WT and CRISPR-mutated fish and between WT under the two dietary regimens by 
unpaired Mann-Whitney test with two-sided significance. Data are presented as means ± confidence interval 
with N = 5 per dietary treatment. Normalization was performed using elongation factor 1α-b (ef1α-b). 
Statistical differences between WT and CRISPR-mutated fish are denoted as asterisks (*p < 0.05, **p < 0.01).
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and Δ5 Fads2 but a precursor upstream of the final Δ6-desaturation (Fig. 1) required for 22:6n-3 synthesis 
was observed. We cannot exclude some contributions of Δ5fads2 knockout on the accumulation of 18:3n-3 and 
18:2n-6, as Atlantic salmon Δ5 Fads2 maintains some Δ6-desaturation activities when heterologously expressed 
in S. cerevisiae16,19. However, this is marginal as salmon Δ5 Fads2 could only convert 0.4 and 0.6% of 18:2n-6 and 
18:3n-3, respectively in S. cerevisiae16. On the other hand, salmon Δ5 Fads2 showed 1.4 and 6.4% conversion 
towards the C24 Δ6-desaturation substrates, 24:4n-6 and 24:5n-3, respectively when expressed in S. cerevisiae19. 
The impact of CRISPR-induced mutations in Δ6abc/5Mt on tissue LC-PUFAs is influenced by dietary PUFA 
composition. Accordingly, accumulation of Δ6-desaturation substrates were observed in Δ6abc/5Mt that were 
fed low LC-PUFA diet which contains high levels of the C18 precursors compared to high LC-PUFA diet. Notably, 
Δ6abc/5Mt demonstrated reduced average weight compared to Δ6bcMt and WT, regardless of dietary treatment 
with DHA-rich diets or low LC-PUFA and high LC-PUFA diets. This probably suggests that impaired LC-PUFA 
biosynthesis in Δ6abc/5Mt compared to Δ6bcMt may have to some extent affected growth; however, this requires 
further studies with specially designed growth trials to ascertain. On the other hand, Δ6bcMt had the highest 
average weight compared to other fish groups when fed low LC-PUFA diet, this was interesting but unexpected, 
and the reason for this observation is unclear. Surprisingly, all experimental fish groups showed relatively higher 
average weight when fed low LC-PUFA diet compared to high LC-PUFA feed. Although the higher total PUFA 
content in low LC-PUFA diet could be a contributory factor, further investigations with higher sample size are 
needed to ascertain these observations. The impact of CRISPR-induced mutations in Δ6bcMt on LC-PUFA syn-
thesis was rather subtle. Thus, while it is expected that knockout of Δ6fads2-b and Δ6fads2-c significantly reduce 
Δ6-desaturation of 18:2n-6 and 18:3n-3, the Δ6bcMt generally demonstrated no or little accumulation of the C18 
precursors compared to WT. This suggests that Δ6fads2-a encodes the main Δ6-desaturation enzyme in the 
salmon tissues analyzed in our study, particularly liver and to some extent white muscle. This result is supported 
by findings obtained from heterologous studies in S. cerevisiae, where Δ6-desaturation activities of salmon Δ6 
Fads2 enzymes are ranked as Δ6 Fads2-a > Δ6 Fads2-b > Δ6 Fads2-c16,17.
Interestingly, accumulation of the Δ8-desaturation substrates was observed in both Δ6abc/5Mt and Δ6bcMt 
fed low LC-PUFA diet, which contains very low levels of the C20 Δ8 precursors. It is probable that the observed 
Δ8-desaturation substrates are products of Elovl5-mediated elongation of 18:2n-6 and 18:3n-338. In support of 
our reasoning, tissue composition of phospholipid 20:3n-3 and 20:2n-6 of fish fed low LC-PUFA diet corre-
lates well with dietary levels of the C18 precursors. Generally, there were no significant differences in the level 
of accumulation of the Δ8-desaturation substrates between Δ6abc/5Mt and Δ6bcMt, suggesting that salmon Δ6 
Fads2-b and Δ6 Fads2-c either individually or collectively have higher Δ8-desaturation activity than Δ6 Fads2-a. 
Further studies are required to confirm the Δ8-desaturation capabilities of Δ6 Fads2-a as Δ8-desaturation activ-
ity has only been investigated for salmon Δ6 Fads2-b and Δ6 Fads2-c13. Additionally, there were no changes in 
the levels of the Δ8-desaturation substrates in Δ6abc/5Mt and Δ6bcMt when fed high dietary LC-PUFAs. This 
suggests that the Δ8 biosynthetic pathway (C18 elongation → C20 Δ8-desaturation → C20 Δ5-desaturation) may 
be activated by high dietary levels of 18:3n-3 and 18:2n-6, and functions together with the Δ6-pathway (C18 
Δ6-desaturation → C18 elongation → C20 Δ5-desaturation) to enhance conversion of C18 precursors to essential 
LC-PUFAs under limiting conditions.
As expected, our gene expression data revealed reduced mRNA levels of CRISPR-target genes including 
Δ6fads2-a, Δ6fads2-b and Δ5fads2 in Δ6abc/5Mt and Δ6fads2-b and Δ6fads2-c in Δ6bcMt. On the other hand, 
Δ6fads2-c expression levels in Δ6abc/5Mt showed no significant reduction. Additionally, an unexpected downreg-
ulation of Δ5fads2 was observed in Δ6bcMt, which is significant in liver but not in pyloric caeca. This was surpris-
ing as the reduced expression in Δ6bcMt is mostly limited to the liver, compared to Δ6abc/5Mt where the targeted 
Δ5fads2 is significantly downregulated both in liver and pyloric caeca when fed high LC-PUFA diet. Even though 
the CRISPR-construct targeting Δ6fads2-b and Δ6fads2-c in Δ6bcMt was pre-validated in silico to ensure high 
on-target specificity, we cannot exclude possibilities of off-target effects. We attempted to assess possible off-target 
indels in liver transcripts using RNAseq data (data to be published in a separate manuscript), even though no 
off-target gene editing was observed, the data was not sufficient to prove with certainty absence of off-target 
indels. Nonsense-mediated mRNA decay (NMD), a translation-dependent mRNA surveillance pathway, has been 
Diet fed over 54 
days Gene
Relative expression in liver Relative expression in pyloric caeca
WT Δ6bcMt Δ6abc/5Mt WT Δ6bcMt Δ6abc/5Mt
Low LC-PUFA
Δ6fads2-a 1.00 ± 0.58 0.63 ± 0.17 0.33 ± 0.32* 1.00 ± 1.47 1.14 ± 0.30 0.32 ± 0.63
Δ6fads2-b 1.00 ± 0.38 0.26 ± 0.16** 0.80 ± 0.99 1.00 ± 1.55 0.47 ± 0.38 1.20 ± 2.14
Δ6fads2-c 1.00 ± 0.53 0.52 ± 0.36 1.89 ± 2.21 1.00 ± 0.18 0.81 ± 0.42 0.66 ± 0.36
Δ5fads2 1.00 ± 0.41 0.37 ± 0.09** 0.17 ± 0.12* 1.00 ± 2.66 1.22 ± 0.48 0.33 ± 0.55
High LC-PUFA
Δ6fads2-a 1.00 ± 0.94 0.67 ± 0.09 0.18 ± 0.11** 1.00 ± 0.17 0.94 ± 0.47 0.15 ± 0.27**
Δ6fads2-b 1.00 ± 0.36 0.50 ± 0.15* 0.41 ± 0.27* 1.00 ± 1.28 0.34 ± 0.22* 0.30 ± 0.33*
Δ6fads2-c 1.00 ± 0.47 0.54 ± 0.08** 0.91 ± 1.06 1.00 ± 0.37 0.53 ± 0.20* 0.91 ± 0.95
Δ5fads2 1.00 ± 0.44 0.50 ± 0.12** 0.07 ± 0.07** 1.00 ± 0.28 0.69 ± 0.60 0.06 ± 0.09**
Table 2. Relative expression of CRISPR-targeted genes in Δ6abc/5Mt and Δ6bcMt fed low and high LC-PUFA 
diets for 54 days. The mRNA expression of CRISPR-targeted genes in Δ6abc/5Mt and Δ6bcMt was determined 
relative to wildtypes (WT), with WT set to 1. Data are presented as means ± confidence interval with N = 5 per 
dietary treatment. Statistical differences between WT and CRISPR-mutated fish are denoted as asterisks and are 
in bold (*p ≤ 0.05, **p < 0.01).
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shown to recognize and eliminate mRNAs containing premature termination codons (PTCs)31. Based on our 
sequence data from direct PCR fragments and sub-cloned PCR products, the Δ6abc/5Mt and Δ6bcMt showed 
out-of-frame mutations in the respective target genes, which would normally generate PTCs. Reduced mRNA 
levels of the fads2 genes in Δ6abc/5Mt appears to correlate well with the expression of srebp-1 suggesting the 
Δ6 fads2 and Δ5fads2 genes are targets of Srebp-1, which is consistent with findings in the Atlantic salmon 
head kidney cells (SHK-1)37. Notably, the reduction in mRNA levels of the fads2 genes in Δ6abc/5Mt appears to 
be influenced by dietary LC-PUFAs, with reduction in mRNA expression being stronger under high LC-PUFA 
diet. These results suggest a LC-PUFA-dependent regulation of the salmon fads2 genes probably in a Srebp-
1-dependent fashion (Fig. 5A,B). Previous in vitro studies in Atlantic salmon SHK-1 cells demonstrated regula-
tion of Srebp-1 and LC-PUFA biosynthetic enzymes by dietary 20:5n-3 and 22:6n-337. In the present study, the 
impaired synthesis of 22:6n-3 in Δ6abc/5Mt appears to significantly upregulate srebp-1 in the liver and pyloric 
caeca under low LC-PUFA diet, which is consistent with results reported from studies in mice36. Our results show 
higher upregulation of srebp-1 in the liver (≈2 folds) than in the pyloric caeca (≈1.5 folds), which is in line with 
the fact that liver is the main metabolic organ controlling systemic lipid metabolism39. Δ6abc/5Mt salmon fed high 
LC-PUFA diet, which contains relatively high levels of 20:5n-3 and 22:6n-3, showed no upregulation of liver or 
intestinal srebp-1, despite significant reduction of 22:6n-3 in the liver. This suggests a feedback-inhibitory effect 
of dietary LC-PUFAs on srebp-1 expression, in line with results previously reported in SHK-1 cells by Minghetti 
et al.37. While it is compelling to reason that increased srebp-1 transcript levels are due to reduced tissue 22:6n-3 
composition, it may also be an overall response to the impaired LC-PUFA biosynthetic pathway. Taken together, 
our findings suggest that the expression levels of srebp-1, at least in the liver and pyloric caeca, is regulated by 
both the status of endogenous LC-PUFA synthesis and by dietary LC-PUFA levels. On the other hand, CRISPR/
Cas9-induced mutations in Δ6abc/5Mt had no major effect on the expression of srebp-2 while expression level 
was downregulated in Δ6bcMt when fed low LC-PUFA diet. The reason for this reduced expression of srebp-2 in 
Δ6bcMt is unclear. Notably, WTs fed low LC-PUFA diet demonstrated significant upregulation of srebp-2 in the 
liver compared to WTs fed high LC-PUFA diet. The low LC-PUFA diet used in our study was partly formulated 
with plant oil which is known to contain phytosterols40 that reduce absorption of dietary cholesterol41. This prob-
ably induced de novo synthesis of cholesterol shown as an upregulation of srebp-2, a major transcription regulator 
of cholesterol biosynthesis in Atlantic salmon42. This observation is consistent with findings from functional 
genomics studies in Atlantic salmon42.
In conclusion, our study points to 20:4n-3 and 18:3n-3/18:2n-6 as the main in vivo substrate of salmon Δ5 
Fads2 and Δ6 Fads2 respectively, and that the salmon Δ6 Fads2 possess Δ8-desaturation activities towards 
20:3n-3 and 20:2n-6 in vivo. Our data also suggest Srebp-1 as a transcription regulator of salmon LC-PUFA bio-
synthesis and further show a combined effect of endogenous LC-PUFA synthesis and dietary LC-PUFA levels on 
the expression of srebp-1.
Materials and Methods
Cloning of target sequences for gRNAs. CRISPR-target sites were selected using a custom-made 
Perl script and publicly available genomic and cDNA sequence data for the Atlantic salmon genes Δ6fads2-a, 
Δ6fads2-b, Δ6fads2-c and Δ5fads2 (Accessions: XM_014170212.1, NM_001172281.1, XM_014170389.1 and 
XM_014170354.1). As salmon fads2 genes have similar coding exon structure with high degree of sequence 
homology17, a single CRISPR-target site was selected for simultaneous CRISPR-mediated edition of Δ6fads2-a, 
Δ6fads2-b, Δ6fads2-c and Δ5fads2 or Δ6fads2-b and Δ6fads2-c. Candidate target sequences were screened 
against the current salmon genome assembly (GCA000233375.4) to avoid off-target genome editing events. For 
easy visual recognition of CRISPR-mutated salmon, slc45a2 involved in melanin synthesis was mutated simul-
taneously with the fads2 genes. Mutagenesis in slc45a2 provided a suitable visual tracer that helps to screen WT 
from mutated fish, as CRISPR-induced mutations in both slc45a2 and interested target genes in Atlantic salmon 
were highly correlated34,35, with fish displaying albino phenotypes peculiar to slc45a2 in addition to phenotypes 
specific for target genes. Thus, mutations in slc45a2 do not seem to influence rate of mutagenesis or phenotypes 
for the target genes. Candidate fads2 target sequences and oligonucleotides used for cloning target sites are listed 
in Supplemental Table 3. To obtain double-stranded DNA inserts for fads2 target sequences, one μg of each for-
ward and reverse oligonucleotide was annealed in T4 ligase buffer (NEB) by incubating at 85 °C for 10 min and 
then cooling to room temperature. One μl of annealed oligonucleotide diluted 1:10 was ligated into 50 ng of the 
BsmBI-linearized pT7-gRNA (Addgene ID# 46759)32 plasmid using T4 DNA ligase (NEB) and transformed into 
competent DH5α cells. Recombinant plasmids were isolated using QIAprep Spin Miniprep kit (Qiagen).
In vitro synthesis of gRNA and Cas9 mRNA. For producing gRNAs for the fads2 genes, the respec-
tive pT7-gRNA plasmids were digested with BamHI-HFTM (NEB) and purified using the DNA Clean and 
ConcentratorTM-5 (ZYMO RESEARCH). The gRNAs were synthesized using the MEGAscript T7 kit (Ambion). 
Synthesized gRNAs were purified using the mirVana and miRNA Isolation kit (Ambion). The gRNA for slc45a2 
was prepared as previously described33. For making the Cas9 nuclease mRNA, the pTST3-nCas9n vector, codon 
optimized for zebrafish (Addgene ID# 46757)32 was digested with XbaI (NEB) and gel-purified using Wizard® 
SV Gel and PCR clean-up system (Promega). Cas9 mRNA was in vitro transcribed using the mMessage mMa-
chine T3 kit (Ambion) and purified using RNeasy Mini Kit Spin column (Qiagen). The integrity of synthesized 
gRNAs and Cas9 mRNA was checked using the RNA 6000 Nano Kit and Agilent 2100 Bioanalyzer (Agilent 
Technologies).
Microinjection. Atlantic salmon sperm and eggs were provided by Aquagen (Trondheim, Norway). Salmon 
eggs were fertilized with sperm in freshwater supplemented with 0.5 mM reduced glutathione at 6–8 °C43 and 
incubated at 6–8 °C for 2–3 h. Embryos were microinjected with 150 ng/μl of Cas9 mRNA and a mixture of two 
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gRNAs each 50 ng/μl in Hepes buffer using the picospritzer III (Parker Automation). One of the gRNAs targets 
slc45a2 and the other simultaneously targets Δ6fads2-a, Δ6fads2-b, Δ6fads2-c and Δ5fads2 or Δ6fads2-b and 
Δ6fads2-c. Uninjected fertilized eggs were kept and used as wildtype controls. Microinjected and uninjected 
eggs were kept in freshwater at 6–8 °C until hatching. Shortly after feeding was started, fully albino juveniles were 
sorted, fin clipped or fully sampled to confirm CRISPR-induced mutations in the target genes. Samples were 
stored in 96% ethanol.
Detection of CRISPR/Cas9-induced mutations. Extraction of genomic DNA from fin clips and tis-
sues of salmon was performed using DNeasy Blood and Tissue Kit (Qiagen). Genomic Regions flanking the 
CRISPR-targets were PCR-amplified using DyNAzyme II DNA Polymerase (Thermo Scientific). Sequences of 
PCR primers are listed in Supplemental Table 4. Using BigDye™ Terminator v3.1 cycle sequencing kit (Applied 
Biosystems™), gel-purified direct PCR fragments and subcloned PCR products in the pCR4 – TOPO® vector 
(Invitrogen) were sequenced. DNA sequencing chromatograms were analyzed using the Unipro UGENE44.
Feeding trial. The feeding trial was carried out at the Institute of Marine Research (Matre, Norway) from 
15th January 2018 to 9th of March 2018. Shortly after hatching, Δ6abc/5Mt, Δ6bcMt and wildtypes (WTs) were 
fed 227 days with standard commercial diet (Nutra Olympic, Skretting Nutreco Company) which provides 
enough of LC-PUFAs (Supplemental Table 2). Notably, after feeding with standard diet, we had no WT with 
exact same size as the CRISPR-mutated fish even though WT were obtained from the same batches of eggs as 
the CRISPR-mutated fish. As the CRISPR-mutated fish and WT were in separate tanks, we suspected that size 
differences between fish may be due to tank variation effects, most likely resulting from differences in density of 
fish per tank (which can influence amount of feed given) as well as size and type of tanks. On the other hand, 
the Δ6bcMt and Δ6abc/5Mt were observed to be similar in size with estimated average weights of 49 g compared 
to WT with estimated average weights of 85 g, and so we cannot rule out impact of fads2 gene knockout on 
growth. Consequently, all three groups of experimental fish were fed 110 days with diets containing higher levels 
of 22:6n-3, DHA-1 and DHA-2 (SPAROS, Portugal), (Supplemental Table 2) until an approximate average weight 
of 85 ± 25 g for Δ6abc/5Mt, 104 ± 25 g Δ6bcMt and 176 ± 34 g WTs (Table 1). Due to the probable tank variation 
effects, we decided to use a “common garden” experimental setup, where all three fish groups were in the same 
tanks during feeding with low LC-PUFA or high LC-PUFA diet (SPAROS, Portugal) and also with DHA-rich 
diets. For the low LC-PUFA and high LC-PUFA feeding trial, six tanks, each containing a total of 18 fish com-
prising of 6 each of Δ6abc/5Mt, Δ6bcMt (Pit-tagged) and WTs were set up. Pit-tags were intended to differentiate 
Δ6bcMt from Δ6abc/5Mt as both had albino phenotypes. Δ6bcMt were identified from Δ6abc/5Mt using ARE-H5 
portable reader (TracID Systems Company). Three tanks were fed a low LC-PUFA diet with reduced 20:5n-3 
and 22:6n-3 content but higher levels of 18:3n-3 and 18:2n-6 (Supplemental Table 2) while the other 3 tanks 
were fed a high LC-PUFA diet rich in 20:5n-3 and 22:6n-3 but reduced composition of 18:3n-3 and 18:2n-6 
(Supplemental Table 2) for 54 days. The feed was supplied continuously and in excess using automatic feeders 
(Arvotec single feeder). The freshwater temperature was 7.7–12.5 °C with at least 70 ppm oxygen saturation at 
the outlet. The average weights and lengths of Δ6abc/5Mt, Δ6bcMt and WTs after the feeding with standard diet, 
22:6n-3 (DHA)-rich diets and low and high LC-PUFA diets are summarized in Table 1. Tissues from 6 fish each 
of Δ6abc/5Mt, Δ6bcMt and WTs per diet were sampled after the 54 days of feeding. White muscle and liver were 
quickly frozen on dry ice and stored at −80 °C until analysis. Tissues of pyloric caeca were first immersed in 
RNALater (Thermo Fisher Scientific) and later stored at −80 °C.
Lipid extraction and GC-MS analysis. Total lipids were extracted from approximately 300 mg of white 
muscle and liver tissues from three fish per dietary treatment according to Folch et al.45. The lipid content per tissue 
was determined gravimetrically. Phospholipids and triacylglycerols (TAG) were separated by high-performance 
thin-layer chromatography (HPTLC) silica gel 60 plates (10 × 10 cm, Merck) using hexane/diethyl ether/acetic 
acid (80:20:2, v/v) as developing solvent46. Lipid classes were visualized through brief exposure to iodine vapor. 
Lipid classes were scraped off and fatty acid methyl esters (FAMEs) produced by acid-catalyzed transesterifica-
tion performed at 50 °C overnight47. FAMEs were identified and quantified using gas chromatography (Agilent 
7890) equipped with mass spectrometer (Agilent 5977B) using 25 m × 0.25 mm capillary column (CP-Wax 52CB, 
Agilent). Helium was used as carrier gas and temperature programming was from 90 °C to 150 °C at 30 °C/min 
and then to 230 °C at 2.5 °C/min and finally to 240 °C at 10 °C/min and held for 23 min.
Preparation of hepatocytes and incubation with 14C-18:3n-3 for assay of fatty acyl desatura-
tion/elongation activities. Hepatocytes from three each of Δ6abc/5Mt and WT salmon fed low LC-PUFA 
diet were prepared as previously described48 with modifications. Liver was dissected, quickly perfused through 
hepatic vein, finely chopped and incubated for 45 mins at 20 °C in 20 ml of solution A (Hank’s balanced salt 
solution with 10 mM Hepes and 1 mM EDTA) containing 1 mg/ml collagenase (Sigma). Digested liver tissues 
were filtered through 100 μm cell strainer (Sigma) and the cells collected by centrifugation at 400 × g for 3 min. 
The cell pellets were washed with 20 ml of solution A containing 10 mg/ml fatty acid free bovine serum albumin 
(FAF-BSA, Sigma) and centrifuged at 400 × g for 3 min. Cell pellets were further washed and resuspended in 5 ml 
of solution B (calcium free minimum essential medium containing 100 U/ml Penicillin, 100 μg/ml Streptomycin 
and 0.25 μg/ml Amphotericin B). For each liver sample, 1.904 ml of hepatocytes and 96 μl of 14C-18:3n-3 with 
approximate final concentration of 4.55 μM (0.5 μCi) was incubated for 2 hours at 20 °C. Cells were thereafter iso-
lated by centrifugation at 400 × g for 2 min and washed with 2 ml solution B containing 10 mg/ml FAF-BSA. Total 
lipids were extracted as described by Folch et al.45. Transmethylation was performed by adding 1 ml toluene and 
2.5 ml 1% (v/v) H2SO4 in methanol and incubating at 50 °C overnight. FAMEs were extracted by adding 2 ml 2% 
(w/v) KHCO3 and 5 ml hexane/diethyl ether (1:1, v/v) containing 0.01% (w/v) butylated hydroxyl toluene (BHT) 
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and then centrifuging at 2879 × g for 5 min. FAMEs in the upper phase were dried under a stream of nitrogen 
and resuspended in 100 μl hexane containing 0.01% BHT. FAMEs were applied as 2 cm streaks on a 20 × 20 silica 
gel TLC plate (Sigma-Aldrich) pre-coated with 0.1 g/ml silver nitrate in acetonitrile. The plate was developed in 
toluene/acetonitrile (95:5, v/v) and then desiccated in the dark for 30 min. Autoradiography was performed by 
placing the plate together with Kodak BioMax MR2 film in an autoradiography exposure cassette for 6 days at 
room temperature and then developed in Carestream Kodak GBX Developer and Carestream Kodak GBX Fixer. 
Percentage radioactivity in n-3 PUFAs was determined by scraping corresponding bands into 1 ml of scintillation 
cocktail and then counted in a liquid scintillation analyser (TRI-CARB 2900TR, Packard).
Tissue RNA isolation and gene expression analysis by RT-qPCR. Total RNA from liver and 
pyloric caeca was extracted using the RNeasy Plus Universal Mini kit (Qiagen) with genomic DNA elimination 
buffer according to the manufacturer’s protocol. Using the Agilent RNA 6000 Nano kit and an Agilent 2100 
Bioanalyzer (Agilent Technologies), the integrity of isolated RNA was checked with an RNA integrity value range 
of 8.9–10 obtained for liver and 6.6–8.8 for pyloric caeca. One μg of total RNA was reverse transcribed using the 
QuantiTect® Reverse Transcription kit (Qiagen) according to the manufacturer’s protocol. A negative control 
with no reverse transcriptase was used to check for genomic DNA contamination. The mRNA expression of 
Δ6fads2-a, Δ6fads2-b, Δ6fads2-c, Δ5fads2, srebp-1, srebp-2, fatty acid synthase-a (fas-a) and fas-b was meas-
ured by RT-qPCR using LightCycler® 96 (Roche). The LinRegPCR analysis program49,50 was used to calculate 
PCR efficiencies and Ct-values from raw amplification data generated from the RT-qPCR. The fold change of 
gene expression between CRISPR-mutated fish and WTs or between WTs under the two dietary regimens was 
determined using the qBase relative quantification framework and software51. Fold changes of gene expression in 
the two individual strains, Δ6abc/5Mt and Δ6bcMt were determined relative to the WTs fed either low LC-PUFA 
or high LC-PUFA diet in order to assess the impact of both CRISPR mutations and dietary treatment on gene 
expression. On the other hand, the effects of only dietary LC-PUFA levels on gene expression was measured by 
determining fold changes of gene expression in WTs fed low LC-PUFA diet relative to WTs under high LC-PUFA 
diet. Elongation factor 1 alpha- b (ef1α-b) pre-validated in Atlantic salmon52 was used as a reference gene. All 
primers used in RT-qPCR are listed in Supplemental Table 5.
Statistical analysis. Weights and lengths of fish fed low and high LC-PUFA diets were analyzed by two-way 
ANOVA using dietary treatment and strain or genotype as experimental factors, followed by multiple compari-
sons of the means using Tukey HSD post-hoc test. Weights and lengths of fish fed DHA-rich diets were analyzed 
by one-way ANOVA using strain as experimental factor, followed by Tukey HSD post-hoc test. Analyses were 
performed using GraphPad Prism 7 software. All fatty acid data are presented as means ± standard deviation with 
N = 3 unless otherwise stated. Statistical differences between CRISPR-mutated fish and WTs were determined by 
two-tailed t-test with unequal variance. All RT-qPCR data are presented as means ± confidence interval (N = 5). 
Differences in gene expression between CRISPR-mutated fish and WTs or between WTs under the two dietary 
regimens were determined by Mann-Whitney test with two-sided significance.
Ethics statement. All experiments on animals were performed in strict accordance with the Norwegian 
Animal Welfare Act of 19th of June 2009. Experiments carried out in this study were approved by the Norwegian 
Animal Research Authority (NARA 5741). Unnecessary pain was avoided by anaesthetizing all fish with Finquel 
MS-222 (Scan Vacc) prior to euthanizing and tissue sampling.
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